Purpose: To assess MTHFR rs1801133 (C677T) gene polymorphism in diabetic patients as a risk factor for diabetic retinopathy and to establish the changes in Platelet indices & count in diabetic patient as compared to the healthy control group. Patients and Methods: The study included 40 patients with Type 2 Diabetes Mellitus. They were divided into 2 equal groups, 20 patients with Diabetic Retinopathy, 20 patients without Diabetic Retinopathy. Patients were selected from those attending the outpatient Ophthalmology Unit and Diabetes Clinic of Al-Zahraa University Hospital in the period from June 2014 to June 2015. Their ages ranged between 34 to 66 years old. They were 14 males and 26 females. Twenty cases apparently healthy individuals were selected as a control group. All cases were subjected to full history taking and complete ophthalmological examination. Also laboratory investigations were done including complete blood picture, kidney and liver function tests, coagulation profile, urine analysis, lipid profile, fasting and postprandial blood sugar and Genetic study for detection of MTHFR gene C677T mutation (rs 1801133)by real time PCR. Results: In all diabetic patients the mutant homozygous TT showed a highly statistically significant increase in FBS (p=0.000), PPBS (p=0.000), HbA1C (p=0.000) and cholesterol (p=0.001) as compared to wild type. Also in all diabetic patients the mutant homozygous TT showed a highly statistically significant increase in FBS (p=0.002), PPBS (p=0.001), HbA1C (p=0.019) and cholesterol (p=0.012) as compared to heterozygous mutant type.
INTRODUCTION
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia. It is one of the common noncommunicable diseases that are increasing globally. Type-2 DM is the most common type (1) .
The chronic hyperglycemia of diabetes is associated with long-term damage, dysfunction, and failure of different organs, especially the eyes. Hyperglycemia contributes to the structural and functional changes in the retina (2) . Diabetic retinopathy is the most common complication of diabetes mellitus and is a leading cause of blindness. It is characterized by increased vascular permeability, tissue ischemia, and neovascularization (3) . Methylenetetrahydrofolate reductase (MTHFR) is an enzyme that catalyzes the transformation of homocysteine to methionine. The enzyme is coded by the gene with the symbol MTHFR on chromosome 1 location p36.3 in humans (4) . Up to 24 numbers of genetic polymorphisms are associated with this gene. The most investigated polymorphisms are C677T (rs1801133) and A1298C (rs1801131) single nucleotide polymorphisms (SNP) (5) . A risk factor for vasculopathy in diabetes is elevated homocysteine level which isa consequence of decreased activity of MTHFR. It has been reported that hyperhomocysteinemia in diabetic patients was associated with the prevalence of diabetic retinopathy as it is associated with slight increase in the risk for arterial and venous thrombosis (6) .
AIM OF THE WORK:
The aim of this work is to study MTHFR rs1801133 (C677T) gene polymorphism in diabetic patients as a risk factor for diabetic retinopathy and to evaluate the changes in platelet indices & count in 629 diabetic patients as compared to healthy control group.
PATIENTS AND METHODS
This study is a prospective, nonrandomized study. It was carried out on 40 patients with type 2 diabetes mellitus. They were divided into 2 equal groups; 20 patients with diabetic retinopathy, and 20 patients without diabetic retinopathy. Patients were selected from those attending the outpatient Diabetes Clinic and Ophthalmology Unit of Al-Zahraa University Hospital in the period between June 2014 and June 2015. Their ages ranged between 34 and 66 years. They were 14 males (35%) and 26 females (65%). A control group included 20 apparently healthy individuals. They were selected with age and sex matched with patients. Their ages ranged between 38 and 62years. They were 8 males (40%) and12 females (60%). Inclusion criteria: Patients with fasting plasma glucose ≥126 mg/dl, Hemoglobin A1c ≥6.5% and/or treatment for diabetes including diet and/or oral antidiabetic drugs to achieve the glycemic control. Pearson correlation coefficients were used to assess the significant relation between two quantitative parameters. The confidence interval was set to 95% and the margin of error accepted was set to 5%. So, the p-value was considered significant as the following: P > 0.05: Non significant, P < 0.05: Significant, P < 0.01: Highly significant.
RESULTS
Demographic data of patients: The age of all studied patients ranged from 34 to 66 years old (Mean+SD was 54.98 ± 8.31 years). They were 14 males (35%) and 26 females (65%) with male to female ratio (1:1.9). Twenty cases apparently healthy individuals were selected as control group and they were age and sex matched with patients. Their ages ranged from 38 to 62 630 years old (Mean+SD was 52.55 ± 7.21 years). They were 8 males (40%)and12 females(60%).The differences between age and sex of all patients compared to the control group were statistically insignificant. As regards the CBC, there was a highly significant decrease in Hb and a highly significant increase in MPV and PDW in all patients compared to the control group.
There were statistically insignificant differences in PT, PTT, coagulation profile, liver and kidney function in all patients group compared to the control group. But there was a statistically highly significant increase in HbA1C, cholesterol, TG, FBS and PPBS in all patients compared to the control group as shown in table (1) . The homozygous mutant type (TT) was detected in 5% of all diabetic patients group while absent in control group. The heterozygous mutant type (CT) was increased (42.5%) in all patients group as compared to the control group (25%) but did not reach statistically significant difference. There was high significant increase in the duration of DM in DR group as compared to DWR group. There was highly significant decrease in Hb in DR and DWR in comparison to the control group. There was significant decrease in platelet count in DR in comparison to the control group. There was a highly significant increase in MPV and PDW in DR than DWR and the control group. There was highly significant increase in FBS, PPBS, HbA1C, cholesterol and TG in DR than DWR and the control group. There was no significant difference in liver and kidney functions between DR, DWR and the control group. The homozygous mutant type (TT) was detected in 10% of DR patients group while it was absent in DWR group and the control group. The heterozygous mutant type (CT) was increased in DR group (50%) as compared to DWR group (35%) and the control group (25%) but did not reach statistically significant difference. The number of T allele was increased in patients with diabetic retinopathy (14) as compared with (7) T alleles in patients without diabetic retinopathy and (5) 
DISCUSSION
Diabetic retinopathy is the most common complication and is a leading cause of blindness. A risk factor for vasculopathy in diabetes is elevated homocysteine levels which are consequence of decreased activity of MTHFR (7) . In the present study, there was a highly significant increase in FBS (p=0.001), PPBS (p=0.001) and HbA1C (p= 0.001) in all diabetic patients compared to the control group. There was a highly significant increase in the duration of DM in patients with DR compared to patients without DR (p=0.001). In the present study, there was a highly significant increase in FBS (p=0.001), PPBS (p=0.001) and HbA1C (p=0.001) in DR patients compared to control group. In the present study, there was a highly significant increase in FBS (p=0.001), PPBS (p=0.001) and HbA1C (p=0.001) in DWR patients compared to control group‫۔‬ In the present study, there was highly significant increase in FBS (p=0.003), PPBS (p=0.017) and HbA1C (p=0.000) in DR patients compared to DWR patients group. These findings were in agreement with (8) . Our results showed that the mean platelet count in the diabetic group with retinopathy was lower than that of the control group with p value (p=0.047) which is significant. Other study done by Hekimosy et al. has observed the same finding with lower platelet count in diabetic group compared to healthy subjects. Our study disagreed with results obtained by Demirtunc et al. and Zuberi et al. who represented higher platelet count. Hence the platelet count could be dependent on several variables as mean platelet survival, platelet production rate, and turnover rate in DM (9) (10) (11) . In the present study, there was a highly significant increase in MPV (p=0.000) in all diabetic patients compared to the control group. There was a highly significant increase in MPV (p=0.001) in DR patients compared to the control group. There was a highly significant increase in MPV (p=0.001) in DWR patients compared to control group. There was a highly significant increase in MPV (p=0.001) in DR patients compared to DWR patients group ‫۔‬
In agreement with the present study results Ayhan Tuzcu et al. reported that there was a correlation between MPV values and DR stage in their study with 192 individuals (12) .
Also the results of the present study were in accordance with Zhong et al. who found that MPV was significantly higher in patients with proliferative DR and proposed that MPV is a risk factor for retinal neovascularization (13) . In contrary to our study Ateş et al. reported that there was no significant difference in MPV value between patients who had background retinopathy and those who developed retinopathy later. Citirik et al. also reported similar results (14) (15) . In the present study, there was a highly significant increase in PDW (p=0.001) in all diabetic patients compared to the control group. In the present study, there was a highly significant increase in PDW (p=0.001) in DR patients compared to the control group. In the present study, there was a highly significant increase in PDW (p=0.001) in DWR patients compared to the control group. In the present study, there was a highly significant increase in PDW (p=0.001) in DR patients compared to DWR patients group.
In concordance with the present study, the results obtained by Jindal et al. found that PDW was significantly increased in patients with T2DM and they reported that it was higher in patients who developed microvascular complications (16) . 632 In contrast to our study Citirik et al. reported that there was insignificant difference in PDW value between patients who had background retinopathy and those who developed retinopathy later (15) . Kakouros et al. suggested that hyperglycemia (both fasting and post prandial) causes to generate larger platelets which is parallel to our results (17) . In our study we used P-values and Coefficients (r). Correlation between MPV and variant parameters (FBG, PDW and duration of DM) and we found highly significant results (p=0.018, p=0.005, p=0.00 7) respectively. In agreement with our results those obtained by Gokce et al. andKodiatte et al. (18) (19) . But Hekimsoy, et al. did not find any correlation between MPV and FBS in patients with type 2 diabetes mellitus. In the present study, there was positive correlation between PDW and FBS in all diabetic patients with p value =0.05 (9) . Results obtained by Demirtunc et al.and Jindal et al. agreed with our results that PDW is correlated with hyperglycemia. In the opposite to our study Khan et al. reported that there is no relation between blood glucose level and PDW (10-16-20) . In our results there was highly significant increase in duration of DM in patients with DR (p=0.001) compared to patients without DR. It was showed that there is positive correlation between HbA1C and duration of DM. Also, there is positive correlation between duration of diabetes in all diabetic patients and MPV (p=0.007), and PDW (p=0.001).
In agreement with our results Bavbeket al. reported that MPV&PDW are correlated with the duration of diabetes mellitus (21) . In contrast with our present study results obtained by Hekimsoy et al. and Kodiatte et al. suggested a relation between MPV and retinopathy but not with diabetes duration (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . In our present study there is no correlation between HbA1c and MPV, PDW and this was agreed with studies done by Unubol et al. (22) . In contrast to our study Shah et al.
showed that HbA1c and diabetes duration has individually induces MPV and PDW changes in adolescents with type 2 diabetes mellitus.
Also studies done by Dalamagaet al. disagreed with our results which revealed that elevated HbA1c concentration was directly correlated with increased MPV and PDW (23) (24) .
Our present study revealed that there was no correlation between MPV and platelet count. While Giovanetti et al. showed an inverse relation between MPV and the platelet count (25) . The association between increased platelet volume and decreased platelet count could be a result of small platelets being consumed in order to maintain a constant platelet functional mass (26) . In the present study, the frequency `of SNP rs 1801133 in all diabetic patients as compared to the control group showed that the homozygous mutant type (TT) was detected in 5% of all diabetic patients group while absent in the control group. The heterozygous mutant type (CT) was increased (42.5%) in all patients groups as compared to the control group (25%).
In agreement with our present study, Naglaa et al. reported a significant difference in the distribution of MTHFR C677T genotypes (p< 0.001) and mutant T allele (p= 0.015) between diabetic patients and the control subjects. MTHFR TT homotype C677T/ was found to be significantly higher in T2DM patients compared to controls, and conferred an almost 3.5-fold increased risk for T2DM (OR: 3.5, 95% CI: 1.06-11.57, p-value: 0.032) (27) . Movva et al. found fourfold risk for developing T2DM with MTHFR TT homotype C677T in Indian population (OR: 4.0423; 95% CI: 1.8753, 8.7133) which was found to be significantly higher in T2DM patients compared to controls (28) . In our present study the homozygous mutant type (TT) was detected in 10% of DR patients group while absent in DWR group and the control group. The heterozygous mutant type (CT) was increased in DR group (50%) as compared to DWR group (35%) and control group (25%).
The number of T allele was increased in patients with diabetic retinopathy (14) as compared with (7) T alleles in patients without diabetic retinopathy and (5) T alleles in the control group.
In our present study as regard fundus changes, T/T (2out of 20) of diabetic patients with retinopathy with fundus changes and the C/C subgroup was (8out of 20) of patients when compared with C/T (10 out of 20).
In agreement with our results, studies done by Abo El Asrar et al. reported that the T/T subgroup and C/T subgroup showed a significantly higher number of patients with fundus changes when compared with the C/C subgroup. This implies that the C677T mutation (rs1801133) in the MTHFR gene could be an independent risk factor for retinopathy (29) . In agreement with our results, Maeda et al. and Wiltshire et al. (2008) found that patients with (T/T) genotype have reduced survival free of retinopathy (30) (31) .
Marginal association between C677T transition and the risk of developing DR was reported by Zintzraras et al. (32) . In contrary to our results, Ukinc et al. did not find any association between diabetic retinopathy and MTHFR gene polymorphism (33) .
On contrary to our results, Abo El Asrar et al. revealed that as regards duration of DM no significant differences were found when the C/C subgroup was compared with C/T and with T/T subgroups (29) . In our present study, in all diabetic patients the mutant homozygous TT shows highly statistically significant increase in FBS (p=0.001), PPBS (p=0.001), HbA1C (p=0.001) and cholesterol (p=0.001) as compared to wild type. Also, in all diabetic patients the mutant homozygous TT shows a statistically highly significant increase in FBS (p=0.002), PPBS (p=0.001), HbA1C (p=0.019) and cholesterol (p=0.012) as compared to heterozygous mutant type.
In agreement with our results Abo El Asrar et al. reported that the TT subroup showed significantly higher HbA1c when compared with the C/T subgroup (29) . On contrary to our results, no significant associations between lipid/glucose metabolic indexes with MTHFR genotypes among diabetic patients were observed by Abo El Asrar et al. and Chang et al. (29) (30) (31) (32) (33) (34) .
CONCLUSION
The homozygous mutant type (TT) of rs1801133 was detected in 10% of DR patients group while absent in DWR group and the control group. The heterozygous mutant type (CT) was increased in DR group (50%) as compared to DWR group (35%) and the control group (25%).
